Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:person
|
| gptkbp:education |
gptkb:Harvard_Medical_School
gptkb:Harvard_University |
| gptkbp:employer |
gptkb:Biogen
gptkb:Voyager_Therapeutics |
| gptkbp:fieldOfWork |
neurology
pharmaceutical industry |
| https://www.w3.org/2000/01/rdf-schema#label |
Alfred W. Sandrock Jr.
|
| gptkbp:nationality |
gptkb:United_States
|
| gptkbp:notableWork |
development of therapies for neurological diseases
involvement in development of Aducanumab |
| gptkbp:occupation |
gptkb:neuroscientist
biopharmaceutical executive |
| gptkbp:position_held |
CEO at Voyager Therapeutics
Chief Medical Officer at Biogen |
| gptkbp:bfsParent |
gptkb:Voyager_Therapeutics
|
| gptkbp:bfsLayer |
7
|